Print Version
Generic Programmatic and Clinical Guide for the Introduction of New Drugs and Shorter Regimen for Treatment of Multi/Extensively Drug-Resistant Tuberculosis
Author:
US Agency for International Development, KNCV Tuberculosis Foundation, KNCV Tuberculosis Foundation, Bureau for Global Health, Office of Health Infectious Diseases and Nutrition, USAID, KNCV
Publication Date:
2016
Format:
Guideline
Language:
English
Abstract
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.Publisher:
US Agency for International Development
Audience(s):
Health Professionals, International Agencies
Topic:
MDR TB, TB Treatment, Extensively Drug-Resistant TB (XCR TB)
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.